Lineage specific treatment of adult patients with acute lymphoblastic leukemia in first remission with anti-B4-blocked ricin or high-dose cytarabine-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lineage specific treatment of adult patients with acute lymphoblastic leukemia in first remission with anti-B4-blocked ricin or high-dose cytarabine

Published:2003-03-03 Issue:6 Volume:97 Page:1471-1480
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Szatrowski Ted P.,Dodge Richard K.,Reynolds Carol,Westbrook Carol A.,Frankel Stanley R.,Sklar Jeffrey,Stewart Carleton C.,Hurd David D.,Kolitz Jonathan E.,Velez-Garcia Enrique,Stone Richard M.,Bloomfield Clara D.,Schiffer Charles A.,Larson Richard A.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference35 articles.

1. A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ricin uses arginine 235 as an anchor residue to bind to P-proteins of the ribosomal stalk;Scientific Reports;2017-02-23

2. Immunotherapy approaches to treat adult acute lymphoblastic leukemia;Expert Review of Hematology;2016-04-08

3. CD19-Targeted Nanodelivery of Doxorubicin Enhances Therapeutic Efficacy in B-Cell Acute Lymphoblastic Leukemia;Molecular Pharmaceutics;2015-05-04

4. MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS;Mediterranean Journal of Hematology and Infectious Diseases;2015-01-01

5. Ribosome-inactivating Proteins in Cancer Treatment;Ribosome-inactivating Proteins;2014-04-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP